A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.
about
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A second dose of kisspeptin-54 ...... 2 randomized controlled trial.
@en
type
label
A second dose of kisspeptin-54 ...... 2 randomized controlled trial.
@en
prefLabel
A second dose of kisspeptin-54 ...... 2 randomized controlled trial.
@en
P2093
P2860
P50
P356
P1433
P1476
A second dose of kisspeptin-54 ...... 2 randomized controlled trial.
@en
P2093
Alexander Nesbitt
Chioma Izzi-Engbeaya
Deborah Papadopoulou
Geoffrey H Trew
Julia K Prague
Rachel Roberts
Rehan Salim
Risheka Ratnasabapathy
Rumana Islam
P2860
P304
P356
10.1093/HUMREP/DEX253
P407
P577
2017-09-01T00:00:00Z